A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy

By Berrak Su  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1163-1168

Springer Publishing Company

Access to resources Recommend Favorite

Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis

By Garcia-del-Muro X.   Vadell C.   Perez Manga G.   Bover I.   Rifa J.   Beltran M.   Barros M.a.M.   Germa J.R.   Fabregat X.   Moreno V.   Salvador A.   Viladiu P.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 193-195

Elsevier

Access to resources Recommend Favorite

Therapeutic Equivalence of Single Oral Doses of Dolasetron Mesilate and Multiple Doses of Ondansetron for the Prevention of Emesis After Moderately Emetogenic Chemotherapy

By European Dolasetron Comparative Study Group   Fauser A.A.   Duclos B.   Chemaissani A.   Del Favero A.   Cognetti F.   Diaz-Rubio E.   Cortes-Funes H.   Conte P.F.   Dressler H.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1523-1529

Elsevier

Access to resources Recommend Favorite

Tropisetron, Ondansetron, and Granisetron for Control of Chemotherapy-Induced Emesis in Turkish Cancer Patients: A Comparison of Efficacy, Side-Effect Profile, and Cost

By Abali Huseyin   Celik Ismail  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 135-139

Informa Healthcare

Access to resources Recommend Favorite

Oral Ondansetron in the Prevention of Chemotherapy-induced Emesis in Breast Cancer Patients

By Clavel M.   Bonneterre J.   d'Allens H.   Paillarse J.-M.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite